Ataxia-telangiectasia (AT) is an autosomal recessive genetic disease characterized by immunological deficiencies, neurological degeneration, developmental abnormalities and an increased risk of cancer. Ataxia-telangiectasia group D (ATDC) was initially described as a gene related to AT. ATDC, also known as TRIM29, is structually a member of the tripartite motif (TRIM) family of proteins, some of which have been reported to be highly expressed in some human carcinomas, but the involvement of TRIM29 in carcinogenesis has not been fully elucidated. In this study, we found by using yeast two-hybrid screening that TRIM29 binds to Tip60, which has been reported as a cellular acetyltransferase protein. Overexpression of TRIM29 promoted degradation and changed localization of Tip60 and reduced acetylation of p53 at lysine 120 by Tip60, resulting in enhancement of cell growth and transforming activity. In addition, we found that TRIM29 suppresses apoptosis induced by UV irradiation in HCT116 cell lines. These findings suggest that TRIM29 functions as an oncogene that promotes tumor growth.
Introduction
Ataxia-telangiectasia (AT) group D (ATDC) has been reported as one of the suppressive genes responsible for the genetic disorder ataxia-telangiectasia (AT) [1] .
AT is a human autosomal recessive genetic disease characterized by immunological deficiencies, neurological degeneration, developmental abnormalities and an increased risk of cancer. Cells isolated from AT patients show hypersensitivity to ionizing radiation, radio-resistant DNA synthesis, elevated recombination, cell cycle abnormalities and aberrant cytoskeletal organization [2] .
The ATDC gene is located at chromosome 11q23 and encodes a 588 amino acid protein. ATDC protein has been reported to be a member of the tripartite motif (TRIM) protein family with multiple zinc-finger motifs and an adjacent leucine-zipper motif that may allow ATDC to form homo-or heterodimers [1] . Therefore, ATDC is also known as TRIM29, which a member of the tripartite motif (TRIM) family. TRIM proteins have a series of conserved domains, which include a RING, a B box type 1 (B1) and B box type 2 (B2), and a coiled-coil (CC) region [3] . While almost all TRIM proteins have these domains, ATDC contains the B1-B2-CC domains but lacks the RING domain.
Several TRIM family members are involved in various cellular processes such as transcriptional regulation, cell growth, apoptosis, development and oncogenesis [4] . So far, it has been reported that TRIM proteins including TRIM19/promyelocytic leukemia protein (PML), TRIM24/transcriptional intermediary factor 1 (TIF1 ) and TRIM27/RET finger protein (RFP) have oncogenic activities as a result of chromosomal translocations [5] [6] [7] .
Though it has been reported that TRIM29 appears to be localized primarily to the cytoplasm, the function of TRIM29 in physiologic or pathologic processes has not been fully elucidated. TRIM29 has been reported to be overexpressed in lung, bladder, colorectal, ovarian and endometrial cancers and in multiple myeloma. Furthermore, a recent study has shown correlations of ATDC expression in gastric cancer with poor histological grade, large tumor size, great extent of tumor invasion and lymph node metastasis.
Tat-interactive protein 60 (Tip60) was originally identified as a cellular acetyltransferase protein that interacts with Tat derived from human immunodeficiency virus-1 (HIV-1) [8] . Tip60 has divergent functions for many processes such as cellular signaling, DNA damage repair, cell cycle, checkpoint control and apoptosis [9] . Tip60 is a tightly regulated transcriptional coregulator [10, 11] , acting in a large multiprotein complex for a range of transcription factors including androgen receptor, Myc, STAT3, NF-B, E2F1 and p53 [12] [13] [14] [15] [16] [17] . Tip60 likely plays an important role in the p53 pathway
[18], but the mechanism by which Tip60 acts on p53 has not been elucidated. Tip60 can acetylate p53 on lysine 120 (K120), which is localized within the DNA-binding domain of p53. This domain, in which mutations are often found in human cancer, is an important region for posttranslational modification of p53, followed by the regulation for transcription or apoptosis. A conservative non-acetylated mutant of K120 is defective for apoptosis induction and activation of p53 proapoptotic target genes (Bax and Puma). However, acetylation of K120 in p53 affects proapoptotic promoters but does not regulate the promoter of p21 [19, 20] .
In this study, with the aim of elucidating the molecular function of TRIM29 in carcinogenesis, we identified Tip60 as a novel TRIM29-binding protein by using yeast two-hybrid screening. TRIM29 reduced the acetylation of p53-K120 via change in the localization and/or degradation of Tip60. We also found that overexpression of TRIM29
promoted cell growth and transforming activity. Moreover, we found that TRIM29 suppressed apoptosis induced by UV irradiation in HCT116 cell lines. These findings may provide evidence for the importance of TRIM29 in carcinogenesis.
Materials and methods

Cell culture
HEK293T and HCT116 cell lines were cultured under an atmosphere of 5% CO 2 
Cloning of cDNAs and plasmid construction
Human TRIM29 cDNAs were amplified from HeLa cDNA by PCR with BlendTaq (Takara, Tokyo, Japan) using the following primers:
5'-GCGATGGAAGCTGCAGATGCCTCC-3' (TRIM29-sense) and
Yeast two-hybrid screening
Complementary DNA encoding the full-length of human TRIM29 was fused in-frame to the nucleotide sequence for the LexA domain (BD) in the yeast two-hybrid vector pBTM116. To screen proteins that interact with TRIM29, we transformed yeast strain L40 (Invitrogen) stably expressing the corresponding pBTM116 vector with a human HeLa cDNA library (Clontech).
Transfection, immunoprecipitation, and immunoblot analysis
HEK293T cells were transfected by the calcium phosphate method and lysed in a solution containing 50 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1% Nonidet P-40, leupeptin (10 g/mL), 1 mmol/L phenylmethylsulfonyl fluoride, 400 mol/L Na 3 VO 4 , 400 mol/L EDTA, 10 mmol/L NaF, and 10 mmol/L sodium pyrophosphate. The cell lysates were centrifuged at 16,000 x g for 10 min at 4°C, and the resulting supernatant was incubated with antibodies for 2 h at 4°C. Protein A-sepharose (Amersham Pharmacia Biotech Inc, Piscataway, NJ) that had been equilibrated with the same solution was added to the mixture, which was then rotated for 1 h at 4°C. The resin was separated by centrifugation, washed five times with ice-cold lysis buffer, and then boiled in SDS sample buffer. Immunoblot analysis was performed with the following primary antibodies: anti-FLAG (1 g/mL; M2 or M5, Sigma), anti-HA (1 g/mL;
HA.11/16B12, Covance, Berkeley, CA), anti-HA (1 g/mL; Y11, Santa Cruz Biotechnology, Santa Cruz, CA), anti-TRIM29 Plat-A packaging cells and then cultured in the presence of puromycin (0.5 g/mL) .
Exposure to UVC
For single exposure of HCT116 cells in a monolayer to UVC, 2 10 5 cells were seeded in a 6-cm dish two days before exposure. The cells were washed with phosphate-buffered saline (PBS) and exposed to UVC ( =254nm) at different doses from 20 to 80 J/cm 2 (UV crosslinker, Funakoshi, Japan).
In vivo p53 acetylation assay
The human colon cancer cell line HCT116 was treated with UV as DNA damage.
The cells were then incubated for 12 h to induce acetylation of p53 in the presence of an inhibitor of deacetylase, trichostatin (0.5 μM). Cell lysates were immunoprecipitaed with anti-p53 antibody (Clone DO-1, sc-126, Santa Cruz) and then immunoblot analysis was performed with anti-K120-acetylated p53 (AcK120-p53) (10E5, Taipei City, Taiwan).
RNA interference
Small interfering RNA (siRNA) oligonucleotide sequences specific for human TRIM29 and p53 mRNA were designed by Silencer Predesigned siRNA (Ambion, Foster City, CA). pSUPER.retro.puro. vectors (OligoEngine, Seattle, WA) containing shRNAs were infected into ACC3 or HCT116 cells. After 24 h, the resulting cell lines were used for immunoblot analysis to detect the expression level of TRIM29.
Cell proliferation assay
HCT116 cells in which TRIM29 or an empty vector (Mock) was stably expressed by using a retroviral expression system were seeded in 10-cm dishes (3 x 10 4 cells) and harvested for determination of cell number at indicated times.
Focus formation assay
NIH 3T3 cell lines stably expressing FLAG-TRIM29 and/or c-Src(Y527F) were plated at a density of 1 x 10 4 cells in 60-mm dishes with drug selection. After 2 weeks, confluent cells on dishes were stained by crystal violet and focus formation was observed under a microscope.
Colony formation assay
For the colony formation assay, 1 x 10 5 cells were plated in 60-mm dishes containing 0.4% soft agar and cultured for 2 weeks. The numbers of colonies with a diameter of >0.125 mm in randomized areas (1 cm 2 ) were counted. 
Apoptosis assay
Statistical analysis
The unpaired Student's t test was used to determine the statistical significance of experimental data.
Results
TRIM29 interacts with and mediates degradation of Tip60
To identify proteins that interact with TRIM29, we screened a pACT2 HeLa cDNA library with pBTM116-hTRIM29 plasmid as a bait by using a yeast two-hybrid system.
We obtained 60 grown clones from 1.25 10 6 transformants in selection medium.
Finally, we obtained two positive clones that may interact with TRIM29 in this screening: Tip60 and Xab2. Interaction between TRIM29 and Tip60 was again confirmed by a -galactosidase assay (Fig. 1A ). To examine whether TRIM29
physically interacts with Tip60 in mammalian cells, we performed an in vivo binding assay using cells transfected with expression vectors. We expressed FLAG-TRIM29
together with HA-Tip60 in HEK293T cells. Cell lysates were subjected to immunoprecipitation with an antibody to HA, and the resulting precipitates were subjected to immunoblot analysis with an antibody to FLAG. FLAG-TRIM29 was co-precipitated by the antibody to HA, indicating that TRIM29 specifically interacts with Tip60 (Fig. 1B) . To further confirm the interaction between endogenous Tip60 and FLAG-TRIM29, we performed an in vivo binding assay using cells transfected with an expression vector encoding FLAG-TRIM29. Immunoblot analysis showed that FLAG-TRIM29 was co-precipitated by the antibody to Tip60, indicating that TRIM29 specifically interacts with Tip60 ( Fig. 1C ).
It has been reported that some TRIM family proteins form homodimers or
heterodimers. There is a possibility that even though TRIM29 has no RING-finger domain, TRIM29 interacts with other TRIM family proteins with a RING-finger domain and affects the stability of Tip60. To examine whether TRIM29 ubiquitinates Tip60, we performed an in vivo ubiquitination assay. However, overexpression of TRIM29 did not enhance polyubiquitination of HA-Tip60 (data not shown). We further examined the effect of TRIM29 on the degradation of endogenous Tip60 in vivo. Immunoblot analysis showed that overexpression of TRIM29 attenuated the expression of endogenous Tip60 in a TRIM29 dose-dependent manner (Fig. 1D) . To determine whether the decrease in expression level of Tip60 is enhanced by proteasome-dependent degradation, we performed immunobolot analysis with anti-Tip60 antibody using cell lysates incubated with the proteasome inhibitor LLnL. Immunoblot analysis showed that the proteasome inhibitor LLnL inhibited the degradation of Tip60, suggesting that degradation of Tip60 by TRIM29 is dependent on proteasome activity (Fig. 1E ).
TRIM29 colocalizes with Tip60
We investigated the effect of TRIM29 on subcellular localization of Tip60. To test each localization, we performed immunofluorescent staining of TRIM29 and Tip60. We transiently transfected FLAG-TRIM29 and HA-Tip60 expression vectors into HeLa cells and stained the cells by using anti-FLAG and anti-HA antibodies. Tip60 was usually expressed in the nucleus, whereas TRIM29 was expressed in the cytosol.
Overexpression of TRIM29 caused a decrease in nuclear staining of Tip60 and an increase in localization of Tip60 in the cytosol (Fig. 2) . Similar results were obtained by using COS7 cells (data not shown). These findings suggest that TRIM29 regulates Tip60 localization and then TRIM29 affects the physiological function of Tip60.
TRIM29 reduces acetylation of p53 at K120 by Tip60
Lysine (K) 120 is located in the L1 loop of the DNA-binding core domain of p53
and is conserved in all known species which encode p53 including humans, mice, D.
melanogaster and C. elegans, suggesting a critical role for this residue in p53 function [20] . Tumor-associated gene mutations of K120 have often been observed in several different types of human cancer [19, 22] . Furthermore, it has been reported that Tip60 induces its acetylation specifically at K120 in the DNA-binding domain and is required for both cell growth arrest and apoptosis mediated by p53 [20] . Taken together, K120
acetylation by Tip60 is crucial for p53-dependent apoptosis. To determine the condition of DNA damage response to induce Tip60-mediated p53 acetylation, we performed immunoblot analysis using an antibody specific to K120-acetylated p53 (AcK120-p53) with the human colorectal carcinoma cell line HCT116 damaged by UV irradiation.
Twenty hours after exposure to UV light (20-80 J/m 2 ), whole-cell extracts at each UV dose were immunoprecipitated with anti-p53 antibody and then immunoblotted with antibodies specific for AcK120-p53. Immunoblot analysis showed that UV-mediated DNA damage induces acetylation of p53 at K120 (Fig. 3A) .
Next, to elucidate the role of TRIM29 in DNA damage-induced p53 activation by Tip60, we tested whether TRIM29 affects K120 acetylation of endogenous p53. Twenty hours after exposure to UV light (80 J/m 2 ), HCT116 cells stably expressing TRIM29 or an empty vector (Mock) were harvested and the acetylation of p53 was analyzed.
Immunoblot analysis showed that HCT116 cells stably expressing TRIM29 had no obvious difference in p53 accumulation upon DNA damage compared to Mock cells but had significantly reduced levels of acetylated p53 at K120 (Fig. 3B) . These results suggest that TRIM29 reduces acetylation of p53 at K120 by Tip60.
TRIM29 suppresses apoptosis induced by UV
Given that TRIM29 causes a decrease in Tip60-mediated acetylation of p53 at K120, overexpression of TRIM29 may inhibit p53-dependent apoptosis by UV treatment. We analyzed the susceptibility to UV-mediated DNA damage using the HCT116 cell line infected with a retrovirus encoding FLAG-TRIM29 or the corresponding empty vector (Mock). The resulting cell lines were treated with UV, incubated for 24 h, and stained with propidium iodide (PI), and the sub-G1 peak was measured by a flowcytomer to detect apoptotic cells according to DNA content.
Flowcytometric analysis showed that approximately 37.4% of Mock cells were apoptotic cells, whereas only 11.1% of TRIM29-expressing cells were counted as apoptotic cells after 24-h UV treatment by flowcytometric analysis (Fig. 4A and B) .
Next, we performed an apoptosis assay using low doses of UV (10 and 20 J/m 2 ). The apoptosis assay showed that overexpression of TRIM29 also suppressed apoptosis induced by low doses of UV (10 and 20 J/m 2 ), suggesting that TRIM29 plays a physiological role in protection against UV irradiation (Fig. 4C) . To clarify the relationship between TRIM29 and p53 in UV-induced apoptosis, p53-knock down cells (HCT116.p53kd) were used for a UV-mediated apoptosis assay. The HCT116 cell line in which p53 was knocked down was further transfected with an expression vector encoding TRIM29 (HCT116.p53kd.TRIM29) (Fig. 4D) . We performed an apoptosis assay using these cell lines. UV-induced apoptosis was inhibited in HCT116.p53kd cells compared with mock. UV-induced apoptosis in HCT116.p53kd.TRIM29 was almost the same as apoptosis in HCT116.p53kd cells and apoptosis in HCT116.TRIM29, indicating that UV-induced apoptosis in HCT116.p53kd is not increased by overexpression of TRIM29 (Fig. 4E) . These findings suggest that TRIM29 does not function as a regulator of an apoptotic pathway other than the p53-mediated apoptotic pathway.
TRIM29 affects cell growth and anchorage-independent growth
It has been reported that overexpression of TRIM29 promotes cell growth of the by retroviral infection. The resulting cell line was further infected with recombinant retroviruses encoding FLAG-TRIM29 (Fig. 5B) . The effect of TRIM29 on cell proliferation was confirmed by focus formation assays using these cell lines. Many foci were formed by the NIH 3T3 cell line expressing c-Src(Y527F), and the NIH 3T3 cell line expressing both c-Src(Y527F) and TRIM29 formed more foci, suggesting that TRIM29 enhances the transformation by oncogenic activity of c-Src(Y527F) (Fig. 5C ).
The ability of these NIH 3T3 cell lines to form colonies in soft agar was also analyzed to evaluate their ability to undergo anchorage-independent growth. Cells that had not been infected c-Src(Y527F) formed few colonies, whereas cells expressing c-Src(Y527F) formed many colonies. The combination of c-Src(Y527F) and TRIM29
increased the ability for anchorage-independent growth ( Fig. 5D and E) . These findings suggest that TRIM29 functions as a positive regulator for anchorage-independent growth.
Knockdown of TRIM29 expression causes cell morphological changes followed by apoptosis
To knock down endogenous TRIM29, we introduced shRNA specific for human TRIM29 (sh-1, sh-2, sh-3) or non-targeting shRNA as a control (sh-control) into the ACC3 cell line in which TRIM29 is highly expressed. The HCT116 cell line was used as a negative control because we confirmed that TRIM29 is not expressed in HCT116 cells (Fig. 6A) . Immunoblot analysis showed that the expression level of TRIM29 was reduced by shRNA for TRIM29 (sh-2 and sh-3). In contrast, TRIM29 protein levels were not significantly decreased in cells infected with sh-1 (Fig. 6B) . The shRNA for TRIM29 (sh-2 and sh-3) caused morphological changes, including rounding of cell shapes and decrease in size, and detachment from the dish, consistent with phenomena often observed in apoptosis (Fig. 6C ). The HCT116 cell line was used as a negative control because we have already confirmed that TRIM29 is not expressed in HCT116 cells. Similar effects were not observed using HCT116 cells. These findings suggest that TRIM29 is required for cell viability for TRIM29-expressing cells and that TRIM29
functions as a positive regulator for cell growth.
Discussion
Our studies demonstrate a functional role of TRIM29 in human tumorigenesis.
TRIM29 has been reported to be overexpressed in lung, bladder, colorectal, ovarian, gastric, pancreatic and endometrial cancers and in multiple myeloma [24] [25] [26] [27] [28] [29] [30] [31] [32] .
Interestingly, opposite results were obtained in melanoma and in breast, head and neck, and prostate cancers [33] [34] [35] [36] [37] [38] focus formation assay and colony formation assay in our study.
Others have reported that the amount of TRIM29 increased in keratinocytes after exposure to UVB and that knock-down of TRIM29 by short-hairpin RNA interference decreases the viability of keratinocytes after UVB exposure, suggesting that TRIM29
participates in the survival of differentiating keratinocytes that are exposed to UVB and pro-death stimuli [41] . We also showed that knock-down of TRIM29 with shRNA causes morphological changes of ACC3 cells in which apoptosis is likely to be induced.
We found that TRIM29 interacts with one of the MYST family acetyltransferases, Tip60, and that overexpression of TRIM29 attenuated expression of endogenous Tip60 in a TRIM29 dose-dependent manner. We could not find that overexpression of TRIM29 enhances polyubiquitination of Tip60. However, overexpression of TRIM29 caused a decrease in nuclear staining of Tip60. These findings suggest that TRIM29 affects the stability of Tip60 via subcellular translocation from the nucleus to the cytosol.
Many recent studies have shown the role for Tip60 in tumorigenesis. Tip60 causes UV-induced transcription of several p53 targets. Post-translational modification of the DNA-binding domain of p53 including acetylation of K120 occurs rapidly after DNA damage and its acetylation is catalyzed by Tip60. Tip60 is required for both cell growth arrest and apoptosis mediated by p53 [39] . Interestingly, this modification is crucial for p53-dependent apoptosis but is dispensable for its mediated growth arrest. Mutation of lysine 120 to arginine, which occurs in human cancer, and the corresponding acetylation-defective tumor mutant (K120R) abrogates p53-mediated apoptosis but not growth arrest. K120R mutation selectively blocks transcription of pro-apoptotic target genes such as Bax and Puma, while the non-apoptotic targets p21 and MDM2 remain unaffected. Consistent with this, depletion of Tip60 inhibits the ability of p53 to activate
Bax and Puma transcription [19, 20] . Actually, in this study, we demonstrated that overexpression of TRIM29 reduces acetylation of p53 at K120 by Tip60 and suppresses apoptosis induced by UV irradiation, suggesting that TRIM29 functions as a negative regulator of p53 via inhibition of Tip60-mediated acetylation.
In conclusion, our observations indicate that TRIM29 is a positive mediator affecting tumor growth, apoptosis, and resistance to UV irradiation, and results of further studies on TRIM29 may be useful for establishing new therapies for cancers, immunological deficiencies, and neurological degeneration accompanying AT.
Moreover, analysis by a genetic approach using transgenic or knock-out mice is needed to clarify physiological functions of TRIM29. were cultured with LLnL (10 μM) for indicated times. Cell lysates were then subjected to immunoblot analysis with anti-Tip60, anti-FLAG and anti--actin antibodies. 
